Cover Image
NEW YORK, USA, Sept. 08, 2026 (GLOBE NEWSWIRE) — Impiricus, the first AI-powered HCP Engagement Engine, has integrated Medvantx, a pharmacy services provider operating one of the largest independent, non-commercial dispensing pharmacies in the United States into its ecosystem. The partnership combines physician engagement with trusted sample management infrastructure, direct-to-provider services, and therapy access solutions.
Medvantx’s sample management and patient support capabilities are now integrated directly into Impiricus Ascend, the company’s agentic commercialization platform delivering on-demand support across the largest network of more than 1 million opted-in healthcare providers through preferred communication channels. With the integration, HCPs engaging with Impiricus can move from conversation to action within the same digital experience, accessing therapy access and fulfillment resources through SMS, chatbots, intelligent media, and other digital channels.
By embedding sample management services and therapy support directly into physician conversations, Impiricus and Medvantx enable pharmaceutical manufacturers to reduce operational friction, simplify care coordination, and accelerate therapy initiation for patients. The experience remains streamlined and consistent across in-office, virtual, and hybrid care environments.
“There’s a specific moment I see in clinic: a patient who’s been living with a flare-up for months, scratching through sleepless nights or hiding their skin under long sleeves in July, and I finally have the right treatment to offer them. Then insurance says: not yet. Maybe in three weeks. Maybe never, if the paperwork gets denied. That wait isn’t abstract to me, it’s a patient’s quality of life on hold. Samples let me close that gap. I can hand someone relief the same day I diagnose them, instead of sending them home to wait on a fax machine. That’s the difference between medicine that helps people and medicine that just exists on paper.” said Dr. Chase Kwon, Dermatologist, Chicago, IL.
The need for this type of workflow-embedded access was reflected in early pilot engagement. Physicians across geographies and time zones engaged with the experience throughout the day and during non-traditional working hours, reinforcing the importance of giving healthcare professionals access to critical patient resources on their own time and within the natural flow of care delivery. The new integration is designed to turn a physician’s need for a resource into an immediate next step.
“Physicians should be able to connect patients to critical treatment resources the moment they are needed, without navigating fragmented systems or administrative barriers,” said Dr. Osama Hashmi, Dermatologist and CEO of Impiricus. “This partnership with Medvantx extends our ability to transform physician engagement into immediate action directly within the clinical workflow. Together, we are helping life sciences organizations create more connected, seamless pathways between engagement, fulfillment, and patient access.”
For healthcare professionals, this new experience is faster, simpler, and fully embedded within existing workflows. Resources can be accessed when they are needed, reducing administrative burden while improving continuity across patient support and fulfillment processes. The model is particularly valuable for specialty therapies, adherence programs, and virtual-first care environments where speed, accessibility, and patient continuity are increasingly critical.
“Healthcare providers and patients increasingly expect access and support to happen seamlessly and in real time,” said Kurt Browning, CEO at Medvantx. “Together with Impiricus, we are helping pharmaceutical manufacturers create more connected patient access experiences that improve therapy initiation, support adherence, and expand access to care.”
The announcement is part of Impiricus’ broader strategy to build a connected ecosystem of trusted healthcare infrastructure partners extending physician engagement into real-time action across the healthcare journey.
For more information, users can visit: https://www.impiricus.com.
About Impiricus
Impiricus is the first Agentic Commercialization Platform for healthcare. Founded by a practicing physician and a senior pharmaceutical executive, Impiricus is transforming how life sciences companies support physicians while accelerating patient access to life-saving treatments. Powered by the largest opted-in network of healthcare providers, our agentic AI platform delivers the right clinical resources, support, and connections exactly when and where physicians need them. Recognized by Deloitte as the #1 fastest-growing company in North America on the 2025 Technology Fast 500, Impiricus provides the agentic AI infrastructure that transforms healthcare commercialization from information delivery to real-time clinical action. Partner with us: https://impiricus.com/contact-us/
About Medvantx
Medvantx is a pharmacy services provider operating one of the largest independent, non-commercial dispensing pharmacies in the U.S. Its licensed pharmacists support medication and medical device distribution and provide nationwide patient support through counseling, education and monitoring of drug interactions. The company leverages technology to connect patients, providers, and healthcare organizations, helping pharmaceutical manufacturers administer patient assistance, bridge/quick start, cash-pay, sample distribution, clinical support, and other commercialization programs that improve access to medications and medical devices. Users can learn more at www.medvantx.com.
Attachment
- Cover Image
CONTACT: EVP, Marketing & Growth Yilan Yang Impiricus [email protected]
